Uncategorized

Are gene-editing therapies patentable? A WIPO side event investigates.

On 6 December, Knowledge Ecology International (KEI) organised an interesting panel on the patentability of new gene- and cell-based medical therapies, as a side...

Dutch Health Care Institute Says No to Medicines Pirate

It seems the Dutch health care system and health care professionals are fed up with the abuse of the orphan medicines regulation, which is...

The last mile: A few suggestions for the WHO Pandemic Agreement’s last two weeks...

This technical briefing note is also available as a PDF here. On 16 April, the Bureau of the Intergovernmental Negotiating Body (INB) to draft and...

Uganda tells ARIPO: No more patents for pharmaceuticals

Uganda has notified the African Regional Intellectual Property Organisation (ARIPO) that pharmaceutical inventions are not eligible for patentability in the country, Managing IP reported. With...

Landmark decision by the World Health Assembly to start negotiations for a pandemic treaty

GENEVA, SWITZERLAND: World Health Organization (WHO) member states today decided to pursue an agreement that can better prepare the world to face future pandemics....

COVID-19 Technology Access Pool (C-TAP): A Promising Human Rights Approach

Authors: Katrina Perehudoff and Jennifer Sellin This article is a reprint, and first appeared on 4 June 2020 in Health and Human Rights. How do we...

Medicines Law & Policy responds to US Health and Human Services Department request for...

On 12 December 2023 the US Health and Human Services Department (HHS) posted a notice and request for comments on “the implications of access...

Time to put a stop to the abuse of orphan drug regulation- the latest...

Today, the Dutch Medical Journal (Nederlands Tijdschrift voor Geneeskunde) reported on the case of lutetium-octreotaat, a cancer drug developed by researchers in the Dutch...

BMJ Commentary: Overriding drug and medical technology patents for pandemic recovery: a legitimate move...

Interest in the use of compulsory licensing is making a comeback in high-income countries in response to concerns about access to Covid-19 vaccines and...

The European Parliament has now explicitly acknowledged the know-how problem too: time to include...

This technical briefing note is also available as a PDF here. We have been calling attention to the problem of sharing know-how necessary for the...